NEOGENOMICS INC Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOGENOMICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEOGENOMICS INC for March 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 16 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | M | 4.78 | 125,000 | 597,500 | 0 | |
Mar 16 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Buy | M | 4.78 | 125,000 | 597,500 | 1,500,000 | 1.4 M to 1.5 M (+9.09 %) |
Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 8.03 | 96,167 | 772,221 | 96,167 | |
Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 30.86 | 98,093 | 3,027,150 | 151,640 | 249.7 K to 151.6 K (-39.28 %) |
Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 8.03 | 96,167 | 772,221 | 249,733 | 153.6 K to 249.7 K (+62.62 %) |
Mar 04 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 28.24 | 20,000 | 564,800 | 30,476 | 50.5 K to 30.5 K (-39.62 %) |
Mar 04 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 28.24 | 2,300 | 64,952 | 40,757 | 43.1 K to 40.8 K (-5.34 %) |
Mar 04 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 28.48 | 25,000 | 712,000 | 125,000 | 150 K to 125 K (-16.67 %) |
Mar 04 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 28.85 | 250,000 | 7,212,500 | 1,375,000 | 1.6 M to 1.4 M (-15.38 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Option Exercise | A | 28.33 | 37,514 | 1,062,772 | 37,514 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Grant | A | 0.00 | 5,824 | 0 | 12,060 | 6.2 K to 12.1 K (+93.39 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Payment of Exercise | F | 0.00 | 499 | 0 | 6,236 | 6.7 K to 6.2 K (-7.41 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 28.33 | 15,006 | 425,120 | 15,006 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Grant | A | 0.00 | 2,330 | 0 | 24,980 | 22.7 K to 25 K (+10.29 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Payment of Exercise | F | 0.00 | 212 | 0 | 22,650 | 22.9 K to 22.7 K (-0.93 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Option Exercise | A | 28.33 | 18,757 | 531,386 | 18,757 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Grant | A | 0.00 | 2,912 | 0 | 43,988 | 41.1 K to 44 K (+7.09 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | A | 28.33 | 48,768 | 1,381,597 | 48,768 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Grant | A | 0.00 | 7,571 | 0 | 333,402 | 325.8 K to 333.4 K (+2.32 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 28.33 | 56,271 | 1,594,157 | 56,271 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Grant | A | 0.00 | 8,736 | 0 | 153,566 | 144.8 K to 153.6 K (+6.03 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 810 | 0 | 144,830 | 145.6 K to 144.8 K (-0.56 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | A | 28.33 | 37,514 | 1,062,772 | 37,514 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Grant | A | 0.00 | 5,824 | 0 | 11,717 | 5.9 K to 11.7 K (+98.83 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 28.33 | 225,084 | 6,376,630 | 225,084 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 34,945 | 0 | 2,316,073 | 2.3 M to 2.3 M (+1.53 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,353 | 0 | 2,281,128 | 2.3 M to 2.3 M (-0.10 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Option Exercise | A | 28.33 | 37,514 | 1,062,772 | 37,514 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Grant | A | 0.00 | 5,824 | 0 | 7,929 | 2.1 K to 7.9 K (+276.67 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 168 | 0 | 2,105 | 2.3 K to 2.1 K (-7.39 %) |